tetano
Editor, Senior Moderator
Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16781. [Epub ahead of print]
Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.
Sieni E[SUP]1[/SUP], Pegoraro F[SUP]1,[/SUP][SUP]2[/SUP], Casini T[SUP]1[/SUP], Tondo A[SUP]1[/SUP], Bortone B[SUP]3[/SUP], Moriondo M[SUP]2,[/SUP][SUP]4[/SUP], Azzari C[SUP]2,[/SUP][SUP]4[/SUP], Galli L[SUP]2,[/SUP][SUP]3[/SUP], Favre C[SUP]1[/SUP].
Author information
Abstract
Since the beginning of coronavirus disease 2019 (COVID-19) pandemic outbreak, it has emerged that the clinical course and outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is definitely more favourable in children than in adults.[SUP]1[/SUP] Few cases of infection in children with cancer are described; also in these patients, except for one reported case,[SUP]2[/SUP] the disease was largely asymptomatic.[SUP]3[/SUP] Nevertheless, the management of COVID-19 in young patients with comorbidities, particularly cancer, remains a challenge for the clinician; further data are required to optimize the clinical approach to these cases.
This article is protected by copyright. All rights reserved.
KEYWORDS:
AML; COVID-19; SARS-CoV-2; children cancer; coronavirus-19; immunosuppression
PMID:32369615DOI:10.1111/bjh.16781
Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.
Sieni E[SUP]1[/SUP], Pegoraro F[SUP]1,[/SUP][SUP]2[/SUP], Casini T[SUP]1[/SUP], Tondo A[SUP]1[/SUP], Bortone B[SUP]3[/SUP], Moriondo M[SUP]2,[/SUP][SUP]4[/SUP], Azzari C[SUP]2,[/SUP][SUP]4[/SUP], Galli L[SUP]2,[/SUP][SUP]3[/SUP], Favre C[SUP]1[/SUP].
Author information
Abstract
Since the beginning of coronavirus disease 2019 (COVID-19) pandemic outbreak, it has emerged that the clinical course and outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is definitely more favourable in children than in adults.[SUP]1[/SUP] Few cases of infection in children with cancer are described; also in these patients, except for one reported case,[SUP]2[/SUP] the disease was largely asymptomatic.[SUP]3[/SUP] Nevertheless, the management of COVID-19 in young patients with comorbidities, particularly cancer, remains a challenge for the clinician; further data are required to optimize the clinical approach to these cases.
This article is protected by copyright. All rights reserved.
KEYWORDS:
AML; COVID-19; SARS-CoV-2; children cancer; coronavirus-19; immunosuppression
PMID:32369615DOI:10.1111/bjh.16781